Samrat T Kundu

7PUBLICATIONS
18CO-AUTHORS
Molecular targetsRehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 09, 2026
PDK1 and YAP1/TEAD signaling drive acquired KRAS inhibitor resistance in KRAS-mutant non-small cell lung cancer.

Amrita Barua, Samrat T Kundu, Sofia G Garza

|May 31, 2023
ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis.

Mabel Perez-Oquendo, Roxsan Manshouri, Yanhua Tian

|Sep 23, 2020
MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs.

Joshua Kapere Ochieng, Samrat T Kundu, Rakhee Bajaj

|Aug 06, 2020
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.

Rakhee Bajaj, Samrat T Kundu, Caitlin L Grzeskowiak

Pageof 2